Clinical Trial Update: Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of AK104 with neoadjuvant chemoradiotherapy in locally advanced rectal cancer with pMMR/MSS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• AK104 (PD-1/CTLA-4 bispecific antibody)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN